No abstract available
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Angiogenesis Inhibitors / administration & dosage
-
Angiogenesis Inhibitors / pharmacology
-
Antineoplastic Combined Chemotherapy Protocols / pharmacology
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Boronic Acids / administration & dosage
-
Boronic Acids / pharmacology*
-
Bortezomib
-
Combined Modality Therapy
-
Dexamethasone / administration & dosage
-
Drug Resistance, Neoplasm / genetics*
-
Epirubicin / administration & dosage
-
Female
-
Gene Expression Regulation, Neoplastic
-
Humans
-
Male
-
Middle Aged
-
Multiple Myeloma / drug therapy*
-
Multiple Myeloma / genetics
-
Multiple Myeloma / radiotherapy
-
Neoplasm Proteins / biosynthesis
-
Neoplasm Proteins / genetics
-
Neoplasm Proteins / physiology*
-
Proteasome Endopeptidase Complex / biosynthesis
-
Proteasome Endopeptidase Complex / genetics
-
Proteasome Endopeptidase Complex / physiology*
-
Pyrazines / administration & dosage
-
Pyrazines / pharmacology*
-
Thalidomide / administration & dosage
-
Up-Regulation
Substances
-
Angiogenesis Inhibitors
-
Boronic Acids
-
Neoplasm Proteins
-
Pyrazines
-
Epirubicin
-
Thalidomide
-
Bortezomib
-
Dexamethasone
-
PSMB5 protein, human
-
Proteasome Endopeptidase Complex